Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients
NCT00347139
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
55
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG:
GW642444 (25, 100 & 400 mcg/day)
DRUG:
Salmeterol 50mcg
Sponsor
GlaxoSmithKline